IL-3 and oncogenic Abl regulate the myeloblast transcriptome by altering mRNA stability

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Ernst, Jason ^a   Ghanem, Louis ^b   Bar Joseph, Ziv ^c   McNamara, Michael ^d   Brown, Jason ^e   Steinman, Richard A ^f  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c Carnegie Mellon University   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e Meadeville Medical Center   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; INTERLEUKIN 3; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTOME; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MYELOBLAST; NUCLEOTIDE SEQUENCE; ONCOGENE; PROTEIN DOMAIN; RNA STABILITY; ANIMAL; BIOLOGY; DNA MICROARRAY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENETICS; GRANULOCYTE PRECURSOR; METABOLISM; METHODOLOGY; MOUSE; PROTEIN MOTIF; RNA PROCESSING;

AMINO ACID MOTIFS; ANIMALS; COMPUTATIONAL BIOLOGY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE PRECURSOR CELLS; HUMANS; INTERLEUKIN-3; MAP KINASE KINASE 1; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-ABL; RESPONSE ELEMENTS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY;

EID: 70449567584     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007469     Document Type: Article

References (63)

1. Steinman RA, Iro A (1999) Suppression of G-CSF-mediated Stat signalling by IL-3. Leukemia 13: 54-61.
2. Steinman RA, Tweardy DJ (1994) Granulocyte colony-stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells. Blood 83: 119-127.
3. Valtieri M, Tweardy DJ, Caracciolo D, Johnson K, Mavilio F, et al. (1987) Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol 138: 3829-3835.
4. Hevehan DL, Wenning LA, Miller WM, Papoutsakis ET (2000) Dynamic model of ex vivo granulocytic kinetics to examine the effects of oxygen tension, pH, and interleukin-3. Exp Hematol 28: 1016-1028.
5. Hevehan DL, Miller WM, Papoutsakis ET (2002) Differential expression and phosphorylation of distinct STAT3 proteins during granulocytic differentiation. Blood 99: 1627-1637.
6. Munoz L, Nomdedeu JF, Lopez O, Carnicer MJ, Bellido M, et al. (2001) Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies. Haematologica 86: 1261-1269.
7. Testa U, Riccioni R, Militi S, Coccia E, Stellacci E, et al. (2002) Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood 100: 2980-2988.
8. Nowak R, Oelschlagel U, Gurth H, Range U, Albrecht S, et al. (1999) Relations between IL-3-induced proliferation and in vitro cytokine secretion of bone marrow cells from AML patients. Cytokine 11: 435-442.
9. Vellenga E, Ostapovicz D, O'Rourke B, Griffin JD (1987) Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia 1: 584-589.
10. Liu J, Joha S, Idziorek T, Corm S, Hetuin D, et al. (2008) BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism. Leukemia 22: 791-799.
11. Stoecklin G, Gross B, Ming XF, Moroni C (2003) A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA. Oncogene 22: 3554-3561.
12. Yen JJ, Yang-Yen HF (2006) Transcription factors mediating interleukin-3 survival signals. Vitam Horm 74: 147-163.
13. Matsui H, Asou H, Inaba T (2007) Cytokines direct the regulation of Bim mRNA stability by heat-shock cognate protein 70. Mol Cell 25: 99-112.
14. Wang P, Wu P, Cheewatrakoolpong B, Myers JG, Egan RW, et al. (1998) Selective inhibition of IL-5 receptor alpha-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils. J Immunol 160: 4427-4432.
15. Chen CY, Shyu AB (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20: 465-470.
16. Xu N, Chen CY, Shyu AB (1997) Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol Cell Biol 17: 4611-4621.
17. Zubiaga AM, Belasco JG, Greenberg ME (1995) The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 15: 2219-2230.
18. Yang E, van Nimwegen E, Zavolan M, Rajewsky N, Schroeder M, et al. (2003) Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes. Genome Res 13: 1863-1872.
19. Sun D, Ding A (2006) MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA. Nat Immunol 7: 375-381.
20. Raghavan A, Dhalla M, Bakheet T, Ogilvie RL, Vlasova IA, et al. (2004) Patterns of coordinate down-regulation of ARE-containing transcripts following immune cell activation. Genomics 84: 1002-1013.
21. Figueroa A, Cuadrado A, Fan J, Atasoy U, Muscat GE, et al. (2003) Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes. Mol Cell Biol 23: 4991-5004.
22. Tenenbaum SA, Carson CC, Lager PJ, Keene JD (2000) Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc Natl Acad Sci U S A 97: 14085-14090.
23. Guchhait P, Tosi MF, Smith CW, Chakaraborty A (2003) The murine myeloid cell line 32Dcl3 as a model system for studying neutrophil functions. J Immunol Methods 283: 195-204.
24. Gaines P, Berliner N (2005) Differentiation and characterization of myeloid cells. Curr Protoc Immunol Chapter 22: Unit 22F 25.
25. Khanna-Gupta A, Zibello T, Sun H, Lekstrom-Himes J, Berliner N (2001) C/ EBP epsilon mediates myeloid differentiation and is regulated by the CCAAT displacement protein (CDP/cut). Proc Natl Acad Sci U S A 98: 8000-8005.
26. Numata A, Shimoda K, Kamezaki K, Haro T, Kakumitsu H, et al. (2005) Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway. J Biol Chem 280: 12621-12629.
27. Ghanem L, Steinman RA (2006) p21Waf1 inhibits granulocytic differentiation of 32Dcl3 cells. Leuk Res 30: 1285-1292.
28. Matulonis U, Salgia R, Okuda K, Druker B, Griffin JD (1993) Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Exp Hematol 21: 1460-1466.
29. Li S, Gillessen S, Tomasson MH, Dranoff G, Gilliland DG, et al. (2001) Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL. Blood 97: 1442-1450.
30. Wang Y, Liu CL, Storey JD, Tibshirani RJ, Herschlag D, et al. (2002) Precision and functional specificity in mRNA decay. Proc Natl Acad Sci U S A 99: 5860-5865.
31. Ernst J, Bar-Joseph Z (2006) STEM: a tool for the analysis of short time series gene expression data. BMC Bioinformatics 7: 191.
32. Systems I (2005) IPA Network Generation Algorithm. available from Ingenuity Systems, Inc.
33. Bakheet T, Williams BR, Khabar KS (2006) ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 34: D111-114.
34. Martinez-Moczygemba M, Huston DP (2003) Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol 112: 653-665; quiz 666.
35. Steinman RA (2007) mRNA stability control: a clandestine force in normal and malignant hematopoiesis. Leukemia 21: 1158-1171.
36. Yang X, Wang W, Fan J, Lal A, Yang D, et al. (2004) Prostaglandin A2-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR. J Biol Chem 279: 49298-49306.
37. Jijon HB, Panenka WJ, Madsen KL, Parsons HG (2002) MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism. Am J Physiol Cell Physiol 283: C31-41.
38. Jaramillo M, Olivier M (2002) Hydrogen peroxide induces murine macrophage chemokine gene transcription via extracellular signal-regulated kinase- and cyclic adenosine 5′-monophosphate (cAMP)-dependent pathways: involvement of NF-kappa B, activator protein 1, and cAMP response element binding protein. J Immunol 169: 7026-7038.
39. Mondal K, Sirenko OI, Lofquist AK, Morris JS, Haskill JS, et al. (2000) Differential role of tyrosine phosphorylation in adhesion-induced transcription, mRNA stability, and cytoskeletal organization in human monocytes. J Leukoc Biol 67: 216-225.
40. Deleault KM, Skinner SJ, Brooks SA (2008) Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Mol Immunol 45: 13-24.
41. Tamura M, Sebastian S, Yang S, Gurates B, Fang Z, et al. (2002) Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2. J Clin Endocrinol Metab 87: 3263-3273.
42. Esnault S, Malter JS (2002) Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-alpha plus fibronectin-activated peripheral blood eosinophils. Blood 99: 4048-4052.
43. Sugiura R, Kita A, Kuno T (2004) Upregulation of mRNA in MAPK signaling: transcriptional activation or mRNA stabilization? Cell Cycle 3: 286-288.
44. Frevel MA, Bakheet T, Silva AM, Hissong JG, Khabar KS, et al. (2003) p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol Cell Biol 23: 425-436.
45. Lam LT, Pickeral OK, Peng AC, Rosenwald A, Hurt EM, et al. (2001) Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol 2: RESEARCH0041.
46. Raghavan A, Ogilvie RL, Reilly C, Abelson ML, Raghavan S, et al. (2002) Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes. Nucleic Acids Res 30: 5529-5538.
47. Ernst J, Nau GJ, Bar-Joseph Z (2005) Clustering short time series gene expression data. Bioinformatics 21 Suppl 1: i159-168.
48. Stoecklin G, Colombi M, Raineri I, Leuenberger S, Mallaun M, et al. (2002) Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. Embo J 21: 4709-4718.
49. Hudson BP, Martinez-Yamout MA, Dyson HJ, Wright PE (2004) Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat Struct Mol Biol 11: 257-264.
50. Amit I, Citri A, Shay T, Lu Y, Katz M, et al. (2007) A module of negative feedback regulators defines growth factor signaling. Nat Genet 39: 503-512.
51. Ghanem L, Steinman R (2005) A proapoptotic function of p21 in differentiating granulocytes. Leuk Res 29: 1315-1323.
52. Billottet C, Grandage VL, Gale RE, Quattropani A, Rommel C, et al. (2006) A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. Oncogene 25: 6648-6659.
53. Sujobert P, Bardet V, Cornillet-Lefebvre P, Hayflick JS, Prie N, et al. (2005) Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. Blood 106: 1063-1066.
54. Sugiyama H, Inoue K, Ogawa H, Yamagami T, Soma T, et al. (1996) The expression of IL-6 and its related genes in acute leukemia. Leuk Lymphoma 21: 49-52.
55. Shimada H, Ichikawa H, Nakamura S, Katsu R, Iwasa M, et al. (2000) Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. Blood 96: 655-663.
56. Zhang W, Kornblau SM, Kobayashi T, Gambel A, Claxton D, et al. (1995) High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia. Clin Cancer Res 1: 1051-1057.
57. Ino T, Yasui H, Hirano M, Kurosawa Y (1995) Identification of a member of the TIS11 early response gene family at the insertion point of a DNA fragment containing a gene for the T-cell receptor beta chain in an acute T-cell leukemia. Oncogene 11: 2705-2710.
58. Huang TS, Myklebust LM, Kjarland E, Gjertsen BT, Pendino F, et al. (2007) LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro. Mol Cancer 6: 31.
59. Calabretta B, Venturelli D, Gewirtz AM (1993) Functional significance of c-myb expression in normal and leukemic hematopoiesis. Cancer Invest 11: 191-197.
60. Bies J, Mukhopadhyaya R, Pierce J, Wolff L (1995) Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms. Cell Growth Differ 6: 59-68.
61. Corradini F, Bussolari R, Cerioli D, Lidonnici MR, Calabretta B (2007) A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells. Blood Cells Mol Dis 39: 292-296.
62. Kim KT, Baird K, Ahn JY, Meltzer P, Lilly M, et al. (2005) Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival. Blood 105: 1759-1767.
63. Chen Y, Haviernik P, Bunting KD, Yang YC (2007) Cited2 is required for normal hematopoiesis in the murine fetal liver. Blood 110: 2889-2898.